|
Henry Schein Inc 's Leverage Ratio
HSIC's quarterly Leverage Ratio and Total Liabilities, Equity growth
Due to net new borrowings of 2.95%, Leverage Ratio fell to 1.36, above the Henry Schein Inc 's average Leverage Ratio.
Within Medical Equipment & Supplies industry in the second quarter 2024, 55 other companies have achieved lower Leverage Ratio than Henry Schein Inc in the II Quarter 2024. While Leverage Ratio total ranking has improved so far in the second quarter 2024 to 1004, from total ranking in the first quarter 2024 at 1314 .
Explain Leverage Ratio?
Who are HSIC Customers?
What are HSIC´s Total Liabilities?
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| HSIC Leverage Ratio |
(Jun 29 2024)
II. Quarter |
(Mar 30 2024)
I. Quarter |
(Dec 30 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jul 01 2023)
II. Quarter |
| Y / Y Equity Change |
-0.91 % |
2.67 % |
4.74 % |
0.82 % |
-0.97 % |
| Y / Y Total Liabilities Change |
24.17 % |
35.29 % |
41.47 % |
29.21 % |
22.56 % |
| Leverage Ratio MRQ |
1.36 |
1.3 |
1.36 |
1.18 |
1.09 |
| HSIC's Total
Ranking |
# 1004 |
# 1314 |
# 950 |
# 2017 |
# 816 |
| Seq. Equity Change |
-2.1 % |
-1.21 % |
0.21 % |
2.25 % |
1.43 % |
| Seq. Total Liabilities Change |
2.95 % |
-5.99 % |
15.62 % |
10.96 % |
12.17 % |
| Leverage Ratio second quarter 2024 Company Ranking |
| Within: |
No. |
| Medical Equipment & Supplies Industry |
# 56 |
| Healthcare Sector |
# 225 |
| Overall Market |
# 1004 |
| Leverage Ratio Statistics |
| High |
Average |
Low |
| 1.57 |
1.06 |
0.74 |
| (Jun 30 2018) |
|
(Mar 31 2012) |
Cumulative Henry Schein Inc 's Leverage Ratio
HSIC's Leverage Ratio for the trailling 12 Months
HSIC Leverage Ratio |
(Jun 29 2024)
II. Quarter |
(Mar 30 2024)
I. Quarter |
(Dec 30 2023)
IV. Quarter |
(Sep 30 2023)
III. Quarter |
(Jul 01 2023)
II. Quarter |
| Y / Y Equity TTM Growth |
-0.91 % |
2.67 % |
4.74 % |
0.82 % |
-0.97 % |
| Y / Y Total Liabilities TTM Growth |
24.17 % |
35.29 % |
41.47 % |
29.21 % |
22.56 % |
| Leverage Ratio TTM |
1.3 |
1.23 |
1.16 |
1.07 |
1 |
| Total
Ranking TTM |
# 5
| # 1527
| # 1136
| # 6
| # 3
|
| Seq. Equity TTM Growth |
-2.1 % |
-1.21 % |
0.21 % |
2.25 % |
1.43 % |
| Seq. Total Liabilities TTM Growth |
2.95 % |
-5.99 % |
15.62 % |
10.96 % |
12.17 % |
On the trailing twelve months basis Due to the net new borrowings of 2.95% during the trailing twelve months finishing in the II Quarter 2024, cumulativeLeverage Ratio improved to 1.3, above the Henry Schein Inc 's average Leverage Ratio. Leverage Ratio is the average cumulative value over the last four quarters.
Among companies in the Medical Equipment & Supplies industry HSIC recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 5, from total ranking in previous 12 month period at 1527.
Explain Leverage Ratio?
Who are HSIC Customers?
What are HSIC´s Total Liabilities?
| TTM Leverage Ratio Company Ranking |
| Within: |
No. |
| Within the Medical Equipment & Supplies Industry |
# 0 |
| Healthcare Sector |
# 0 |
| Within the Market |
# 5 |
| trailing twelve months Leverage Ratio Statistics |
| High |
Average |
Low |
| 1.66 |
1.2 |
0.99 | | (Jun 30 2018) |
|
(Mar 27 2021) |
| Companies with similar Leverage Ratio in the quarter ending Jun 29 2024, within Medical Equipment & Supplies Industry | Leverage Ratio | Jun 29 2024 MRQ Total Liabilities | Jun 29 2024 MRQ Equity | | Apyx Medical Corporation | 3.39 | $ 50.647 Millions | $ 14.924 Millions | | Bioventus Inc | 3.39 | $ 641.238 Millions | $ 189.062 Millions | | Strata Skin Sciences Inc | 3.17 | $ 30.085 Millions | $ 9.496 Millions | | Tandem Diabetes Care Inc | 2.74 | $ 641.638 Millions | $ 233.875 Millions | | Zynex inc | 2.59 | $ 84.987 Millions | $ 32.816 Millions | | The Pennant Group Inc | 2.58 | $ 446.932 Millions | $ 172.993 Millions | | Ir med Inc | 2.45 | $ 0.891 Millions | $ 0.363 Millions | | Baxter International Inc | 2.42 | $ 18,669.000 Millions | $ 7,708.000 Millions | | Cytosorbents Corporation | 2.19 | $ 36.690 Millions | $ 16.737 Millions | | Stereotaxis Inc | 2.17 | $ 24.658 Millions | $ 11.356 Millions | | Novocure Limited | 2.13 | $ 771.413 Millions | $ 361.750 Millions | | Patterson Companies Inc | 1.92 | $ 1,828.508 Millions | $ 952.501 Millions | | Insulet Corporation | 1.89 | $ 1,883.200 Millions | $ 998.400 Millions | | Dexcom Inc | 1.75 | $ 4,251.800 Millions | $ 2,434.300 Millions | | Artivion Inc | 1.68 | $ 494.483 Millions | $ 295.056 Millions | | Haemonetics Corporation | 1.63 | $ 1,478.553 Millions | $ 905.368 Millions | | Predictive Oncology Inc | 1.59 | $ 6.493 Millions | $ 4.094 Millions | | Conmed Corporation | 1.52 | $ 1,338.840 Millions | $ 881.832 Millions | | Vivos Therapeutics Inc | 1.50 | $ 9.495 Millions | $ 6.347 Millions | | Adm Tronics Unlimited Inc | 1.46 | $ 1.487 Millions | $ 1.020 Millions | | Integra Lifesciences Holdings Corp | 1.42 | $ 2,181.996 Millions | $ 1,534.195 Millions | | Nuo Therapeutics Inc | 1.37 | $ 0.822 Millions | $ 0.599 Millions | | Henry Schein Inc | 1.36 | $ 5,652.000 Millions | $ 4,148.000 Millions | | Therapeutic Solutions International Inc | 1.34 | $ 2.461 Millions | $ 1.836 Millions | | Dentsply Sirona Inc | 1.25 | $ 3,833.000 Millions | $ 3,064.000 Millions | | Nexgel Inc | 1.24 | $ 5.609 Millions | $ 4.527 Millions | | Avinger Inc | 1.23 | $ 9.542 Millions | $ 7.753 Millions | | Msa Safety Inc | 1.17 | $ 1,209.924 Millions | $ 1,033.647 Millions | | 1.13 | $ 19.209 Millions | $ 16.983 Millions | | Masimo Corp | 1.11 | $ 1,525.100 Millions | $ 1,368.800 Millions |
|
